Mumbai | 02-Oct-2025, 11:00 IST — Filed via NSE corporate actions
Glenmark Pharmaceuticals Ltd (NSE: GLENMARK) has announced an interim dividend of ₹2.50 per equity share (face value ₹1 each) for FY2025. According to the exchange filing, the ex-dividend date has been set as October 3, 2025, and the record date will follow to determine shareholder eligibility.
The payout reflects the company’s policy of returning value to shareholders amid steady operating performance. While Glenmark’s revenues are driven by its generics and specialty portfolio across India, the US, and regulated markets, the interim dividend underscores confidence in cash generation.
Key Dividend Details
| Detail | Value |
|---|---|
| Dividend Type | Interim Dividend |
| Dividend Amount | ₹2.50/share |
| Face Value | ₹1/share |
| Ex-Date | Oct 3, 2025 |
| Record Date | To be notified |
Why It Matters
- Shareholder returns: The dividend is modest, but adds to cumulative payouts, highlighting steady balance sheet strength.
- Pharma sector context: Larger Indian pharma players, including Sun Pharma and Dr. Reddy’s, have also maintained dividend payouts alongside ongoing R&D spends, reflecting healthy cash flows.
- Investor focus: Alongside dividends, investors will track Glenmark’s pipeline launches and margin trajectory in the generics and specialty segments.
Market Reaction
Glenmark’s stock has been actively traded in the run-up to the corporate action. Historically, Indian pharma stocks tend to see small upticks before dividend record dates as investors position themselves for payouts.
The ex-date on October 3 means trades executed on or after this date will not be eligible for the interim dividend, making October 2 the last cum-dividend date.
While the interim dividend is modest relative to share price, it signals the company’s ability to maintain stable distributions while funding growth. Investors will also be watching upcoming quarterly results for updates on US generics approvals, specialty launches, and margin resilience.
| Metric | Value | Metric | Value |
|---|---|---|---|
| Mkt Cap | ₹55.25K Cr | P/E Ratio | 73.32 |
| 52-Week High | ₹2,284.80 | 52-Week Low | ₹1,275.50 |
| Dividend Yield | 0.19% | Qtrly Div Amt | ₹0.93 |
